Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Genetic Engineering Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Biotech Pharmaceutical
Tonghua Dongbao Pharmaceutical
3SBio
Beijing SL Pharmaceutical
Shenzhen Neptunus Interlong Bio-Technique
Anhui Anke Biotechnology
Jiangsu Sihuan Bioengineering
GeneScience Pharmaceuticals
Shanghai Lansheng Guojian Pharmaceutical
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Monoclonal Antibody
Recombinant Human Erythropoietin
Recombinant Human Interferon
Recombinant Human Growth Hormone
Recombinant Human Insulin
Application:
＜30 Years Old
30 Years Old-60 Years Old
＞60 Years Old
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Genetic Engineering Drug Industry Overview
-
1.1.1 Genetic Engineering Drug Market Scope and Market Segments
-
1.1.2 Genetic Engineering Drug Industry Characteristics
-
1.1.3 Global and China Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Genetic Engineering Drug Production Value and Growth Rate (2017-2028)
-
1.2 Global Genetic Engineering Drug Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Monoclonal Antibody
-
1.2.2 Recombinant Human Erythropoietin
-
1.2.3 Recombinant Human Interferon
-
1.2.4 Recombinant Human Growth Hormone
-
1.2.5 Recombinant Human Insulin
-
1.3 Global Genetic Engineering Drug Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 ＜30 Years Old
-
1.3.2 30 Years Old-60 Years Old
-
1.3.3 ＞60 Years Old
-
1.4 Market Analysis by Region
-
1.4.1 North America Genetic Engineering Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Genetic Engineering Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Genetic Engineering Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Genetic Engineering Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Genetic Engineering Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Genetic Engineering Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Genetic Engineering Drug Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Genetic Engineering Drug Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Genetic Engineering Drug Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Genetic Engineering Drug Industry Porter's Five Forces Model Analysis
-
2.2.3 Genetic Engineering Drug Industry PEST Analysis
-
2.3 Genetic Engineering Drug Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Genetic Engineering Drug Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Genetic Engineering Drug Industry
Chapter 3 Global and China Genetic Engineering Drug Market, by Manufacturer
-
3.1 Global and China Genetic Engineering Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Genetic Engineering Drug Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Genetic Engineering Drug Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Genetic Engineering Drug Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Genetic Engineering Drug Market Top 3 Players
Chapter 4 Global and China Genetic Engineering Drug Market, by Type (2017-2028)
-
4.1 Genetic Engineering Drug Market Trend, by Type
-
4.2 Global Genetic Engineering Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Genetic Engineering Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Genetic Engineering Drug Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Genetic Engineering Drug Price Trend, by Type (2017-2028)
-
4.3 China Genetic Engineering Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Genetic Engineering Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Genetic Engineering Drug Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Genetic Engineering Drug Price Trend, by Type (2017-2028)
Chapter 5 Global and China Genetic Engineering Drug Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Genetic Engineering Drug Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Genetic Engineering Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Genetic Engineering Drug Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Genetic Engineering Drug Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Genetic Engineering Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Genetic Engineering Drug Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Genetic Engineering Drug Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Genetic Engineering Drug Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Genetic Engineering Drug Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Genetic Engineering Drug Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Genetic Engineering Drug Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Genetic Engineering Drug Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Genetic Engineering Drug Market Analysis
-
7.1 North America Genetic Engineering Drug Market, by Type
-
7.2 North America Genetic Engineering Drug Market, by Application
-
7.3 North America Genetic Engineering Drug Market Analysis and Forecast, by Country
-
7.3.1 United States Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Genetic Engineering Drug Market Analysis
-
8.1 Europe Genetic Engineering Drug Market, by Type
-
8.2 Europe Genetic Engineering Drug Market, by Application
-
8.3 Europe Genetic Engineering Drug Market Analysis and Forecast, by Country
-
8.3.1 Germany Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Genetic Engineering Drug Market Analysis
-
9.1 APAC Genetic Engineering Drug Market, by Type
-
9.2 APAC Genetic Engineering Drug Market, by Application
-
9.3 APAC Genetic Engineering Drug Market Analysis and Forecast, by Country
-
9.3.1 China Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Genetic Engineering Drug Market Analysis
-
10.1 Latin America, Middle East and Africa Genetic Engineering Drug Market, by Type
-
10.2 Latin America, Middle East and Africa Genetic Engineering Drug Market, by Application
-
10.3 Latin America, Middle East and Africa Genetic Engineering Drug Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Genetic Engineering Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Genetic Engineering Drug Company Profiles
-
11.1 Biotech Pharmaceutical
-
11.1.1 Biotech Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Biotech Pharmaceutical Genetic Engineering Drug Product Profiles, Application and Specification
-
11.1.3 Biotech Pharmaceutical Genetic Engineering Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Tonghua Dongbao Pharmaceutical
-
11.2.1 Tonghua Dongbao Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product Profiles, Application and Specification
-
11.2.3 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 3SBio
-
11.3.1 3SBio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 3SBio Genetic Engineering Drug Product Profiles, Application and Specification
-
11.3.3 3SBio Genetic Engineering Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Beijing SL Pharmaceutical
-
11.4.1 Beijing SL Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Beijing SL Pharmaceutical Genetic Engineering Drug Product Profiles, Application and Specification
-
11.4.3 Beijing SL Pharmaceutical Genetic Engineering Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Shenzhen Neptunus Interlong Bio-Technique
-
11.5.1 Shenzhen Neptunus Interlong Bio-Technique Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product Profiles, Application and Specification
-
11.5.3 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Anhui Anke Biotechnology
-
11.6.1 Anhui Anke Biotechnology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Anhui Anke Biotechnology Genetic Engineering Drug Product Profiles, Application and Specification
-
11.6.3 Anhui Anke Biotechnology Genetic Engineering Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Jiangsu Sihuan Bioengineering
-
11.7.1 Jiangsu Sihuan Bioengineering Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product Profiles, Application and Specification
-
11.7.3 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 GeneScience Pharmaceuticals
-
11.8.1 GeneScience Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 GeneScience Pharmaceuticals Genetic Engineering Drug Product Profiles, Application and Specification
-
11.8.3 GeneScience Pharmaceuticals Genetic Engineering Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Shanghai Lansheng Guojian Pharmaceutical
-
11.9.1 Shanghai Lansheng Guojian Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product Profiles, Application and Specification
-
11.9.3 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Genetic Engineering Drug Industry Investment Prospect and Risk Assessment
-
12.1 Genetic Engineering Drug Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Genetic Engineering Drug Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Global Genetic Engineering Drug Production Value and Growth Rate (2017-2028)
-
Figure China Genetic Engineering Drug Production Value and Growth Rate (2017-2028)
-
Figure Global Genetic Engineering Drug Market Size and Growth Rate of Monoclonal Antibody (2017-2028)
-
Figure Global Genetic Engineering Drug Market Size and Growth Rate of Recombinant Human Erythropoietin (2017-2028)
-
Figure Global Genetic Engineering Drug Market Size and Growth Rate of Recombinant Human Interferon (2017-2028)
-
Figure Global Genetic Engineering Drug Market Size and Growth Rate of Recombinant Human Growth Hormone (2017-2028)
-
Figure Global Genetic Engineering Drug Market Size and Growth Rate of Recombinant Human Insulin (2017-2028)
-
Figure Global Genetic Engineering Drug Market Size and Growth Rate of ＜30 Years Old (2017-2028)
-
Figure Global Genetic Engineering Drug Market Size and Growth Rate of 30 Years Old-60 Years Old (2017-2028)
-
Figure Global Genetic Engineering Drug Market Size and Growth Rate of ＞60 Years Old (2017-2028)
-
Figure North America Genetic Engineering Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Genetic Engineering Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Genetic Engineering Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Genetic Engineering Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Genetic Engineering Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Genetic Engineering Drug Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Genetic Engineering Drug Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Genetic Engineering Drug Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Genetic Engineering Drug Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Genetic Engineering Drug Market Share, by Manufacturer in 2021
-
Figure Global and China Genetic Engineering Drug Market Share, by Manufacturer in 2022
-
Table Global Genetic Engineering Drug Sales Volume, by Type (2017-2028)
-
Table Global Genetic Engineering Drug Sales Volume Share, by Type (2017-2028)
-
Figure Global Genetic Engineering Drug Sales Volume Share, by Type (2017-2028)
-
Table Global Genetic Engineering Drug Sales Value, by Type (2017-2028)
-
Table Global Genetic Engineering Drug Sales Value Share, by Type (2017-2028)
-
Figure Global Genetic Engineering Drug Price Trend, by Type (2017-2028)
-
Table China Genetic Engineering Drug Sales Volume, by Type (2017-2028)
-
Table China Genetic Engineering Drug Sales Volume Share, by Type (2017-2028)
-
Figure China Genetic Engineering Drug Sales Volume Share, by Type (2017-2028)
-
Table China Genetic Engineering Drug Sales Value, by Type (2017-2028)
-
Table China Genetic Engineering Drug Sales Value Share, by Type (2017-2028)
-
Figure China Genetic Engineering Drug Price Trend, by Type (2017-2028)
-
Table Global Genetic Engineering Drug Sales Volume, by Application (2017-2028)
-
Table Global Genetic Engineering Drug Sales Volume Share, by Application (2017-2028)
-
Figure Global Genetic Engineering Drug Sales Volume Share, by Application (2017-2028)
-
Table Global Genetic Engineering Drug Sales Value, by Application (2017-2028)
-
Table Global Genetic Engineering Drug Sales Value Share, by Application (2017-2028)
-
Figure Global Genetic Engineering Drug Sales Value Share, by Application (2017-2028)
-
Table China Genetic Engineering Drug Sales Volume, by Application (2017-2028)
-
Table China Genetic Engineering Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Genetic Engineering Drug Sales Volume Share, by Application (2017-2028)
-
Table China Genetic Engineering Drug Sales Value, by Application (2017-2028)
-
Table China Genetic Engineering Drug Sales Value Share, by Application (2017-2028)
-
Figure China Genetic Engineering Drug Sales Value Share, by Application (2017-2028)
-
Figure China Genetic Engineering Drug Production, Import, Consumption and Export (2017-2022)
-
Figure North America Genetic Engineering Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Genetic Engineering Drug Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Genetic Engineering Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Genetic Engineering Drug Production, Import, Consumption and Export (2017-2022)
-
Table North America Genetic Engineering Drug Sales Volume, by Type (2017-2028)
-
Table North America Genetic Engineering Drug Sales Volume Share, by Type (2017-2028)
-
Figure North America Genetic Engineering Drug Sales Volume Share, by Type (2017-2028)
-
Table North America Genetic Engineering Drug Sales Volume, by Application (2017-2028)
-
Table North America Genetic Engineering Drug Sales Volume Share, by Application (2017-2028)
-
Figure North America Genetic Engineering Drug Sales Volume Share, by Application (2017-2028)
-
Figure United States Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure United States Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Figure Canada Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Table Europe Genetic Engineering Drug Sales Volume, by Type (2017-2028)
-
Table Europe Genetic Engineering Drug Sales Volume Share, by Type (2017-2028)
-
Figure Europe Genetic Engineering Drug Sales Volume Share, by Type (2017-2028)
-
Table Europe Genetic Engineering Drug Sales Volume, by Application (2017-2028)
-
Table Europe Genetic Engineering Drug Sales Volume Share, by Application (2017-2028)
-
Figure Europe Genetic Engineering Drug Sales Volume Share, by Application (2017-2028)
-
Figure Germany Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Figure UK Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure UK Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Figure France Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure France Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Figure Italy Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Figure Spain Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Figure Poland Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Figure Russia Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Table APAC Genetic Engineering Drug Sales Volume, by Type (2017-2028)
-
Table APAC Genetic Engineering Drug Sales Volume Share, by Type (2017-2028)
-
Figure APAC Genetic Engineering Drug Sales Volume Share, by Type (2017-2028)
-
Table APAC Genetic Engineering Drug Sales Volume, by Application (2017-2028)
-
Table APAC Genetic Engineering Drug Sales Volume Share, by Application (2017-2028)
-
Figure APAC Genetic Engineering Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Figure Japan Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Figure India Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure India Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Genetic Engineering Drug Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Genetic Engineering Drug Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Genetic Engineering Drug Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Genetic Engineering Drug Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Genetic Engineering Drug Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Genetic Engineering Drug Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Genetic Engineering Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Genetic Engineering Drug Sales Value and Growth Rate (2017-2028)
-
Table Biotech Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Biotech Pharmaceutical Product Profiles, Application and Specification
-
Table Biotech Pharmaceutical Genetic Engineering Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Tonghua Dongbao Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Tonghua Dongbao Pharmaceutical Product Profiles, Application and Specification
-
Table Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table 3SBio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table 3SBio Product Profiles, Application and Specification
-
Table 3SBio Genetic Engineering Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Beijing SL Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Beijing SL Pharmaceutical Product Profiles, Application and Specification
-
Table Beijing SL Pharmaceutical Genetic Engineering Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Shenzhen Neptunus Interlong Bio-Technique Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Shenzhen Neptunus Interlong Bio-Technique Product Profiles, Application and Specification
-
Table Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Anhui Anke Biotechnology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Anhui Anke Biotechnology Product Profiles, Application and Specification
-
Table Anhui Anke Biotechnology Genetic Engineering Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Jiangsu Sihuan Bioengineering Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Jiangsu Sihuan Bioengineering Product Profiles, Application and Specification
-
Table Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GeneScience Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GeneScience Pharmaceuticals Product Profiles, Application and Specification
-
Table GeneScience Pharmaceuticals Genetic Engineering Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Shanghai Lansheng Guojian Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Shanghai Lansheng Guojian Pharmaceutical Product Profiles, Application and Specification
-
Table Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
